Girish Mahajan (Editor)

Co amilozide

Updated on
Edit
Like
Comment
Share on FacebookTweet on TwitterShare on LinkedInShare on Reddit
Hydrochlorothiazide
  
Thiazide diuretic

ATC code
  
C03EA01 (WHO)

Routes of administration
  
Oral

Amiloride
  
Potassium-sparing diuretic

AHFS/Drugs.com
  
International Drug Names

Legal status
  
UK: POM (Prescription only)

Co-amilozide (BAN) is a non-proprietary combination of amiloride and hydrochlorothiazide. Co-amilozide is used in the treatment of hypertension and congestive heart failure with the tendency of the thiazide to cause low potassium levels (hypokalaemia) offset by the potassium-sparing effects of amiloride.

Contents

Formulation

Two strengths of co-amilozide are currently available in the UK:

  • 2.5 mg amiloride and 25 mg hydrochlorothiazide, BAN of Co-amilozide 2.5/25 (brand name Moduret 25)
  • 5 mg amiloride and 50 mg hydrochlorothiazide, BAN of Co-amilozide 5/50 (brand name Moduretic)

    • In North America:

  • Moduretic (U.S., Canada)
  • Moduretic 5-50 (U.S., Canada)
  • Novamilor (Canada)

    • Side effects

    The most common side effect is headache (about 8% of people taking it) and nausea, loss of appetite, weakness, rash and dizziness (each about 3%).

    Common side effects (1/10 - 1/100) include:

  • General: Weakness, fatigue, loss of appetite. Headache, dizziness.
  • Circulatory system: Arrhythmia.
  • Gastrointestinal: Nausea, diarrhea, abdominal pain.
  • Skin: Exanthema, itching.
  • Respiratory system: dyspnoea, cough.
  • Metabolic.: Hyperglycemia in diabetic patients, hyperuricemia.
  • Musculoskeletal.: Pain in the limbs.

    • References

    Co-amilozide Wikipedia
    (Text) CC BY-SA